Skip to main content

Advertisement

Log in

Triple approach for diagnosis and grading of meningiomas: Histology, morphometry of Ki-67/feulgen stainings, and cytogenetics

  • Clinical Articles
  • Published:
Acta Neurochirurgica Aims and scope Submit manuscript

Summary

With regard to meningioma grading and the recently introduced “atypical” meningioma, we evaluated 160 cases retrospectively by conventional histology and image analysis. For that, the cell nuclei were stained with a Ki-67 (MIB1)/Feulgen-method on paraffin sections, thus enabling the assessment of both the Ki-67 proliferation index and nuclear morphometric features, such as tumour cell arrangement, nuclear pleomorphism, and cellularity.

It could be demonstrated that the Ki-67 proliferation index is the most important criterion for distinguishing anaplastic meningiomas (WHO “grade” III) (mean Ki-67 index: 11%) from those of common type (WHO “grade” I) (mean Ki-67 index: 0.7%). The parameter for the “relative volume weighted mean nuclear volume” is another valuable morphometric feature. The “atypical” meningioma (WHO “grade” II) which should represent an intermediate category between common type and anaplastic meningiomas is characterized by a mean Ki-67 proliferation index of 2.1%. Common type meningiomas which comprise almost 50% of the cases of this series have a relapse rate of 9%. “Atypical” and anaplastic meningiomas recurred in 29% and 50%, respectively. Since the term “atypical” meningioma is confusing in the context of tumour grading, the term “intermediate type meningioma” is proposed.

Furthermore, the results of cytogenetic analyses of 142 cases of this series were evaluated and compared with the meningioma grades. Thereby, 25 cases disclosed, independent of the typical loss of one chromosome 22, cytogenetic features assumed to be progression-associated, e.g., the gain or loss of different chromosomes and the deletion of the short arm of one chromosome 1 (hyperdiploidy, increased hypodiploidy, Ip-), when correlated to the histological and morphometric findings or the high relapse rate.

For meningioma diagnosis and grading, a practical guideline is proposed based upon histology, morphometry (Ki-67), and cytogenetics.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Baird M, Gallagher PJ (1989) Recurrent intracranial and spinal meningiomas: clinical and histological features. Clin Neuropathol 8: 41–44

    PubMed  Google Scholar 

  2. Bello MJ, de Campos JM, Kusak ME, Vaquero J, Sarasa JL, Pestana A, Rey JA (1994) Allelic loss at 1p is associated with tumor progression of meningiomas. Genes Chrom Cancer 9: 296–298

    PubMed  Google Scholar 

  3. Black P (1993) Meningiomas. Neurosurgery 32: 643–657

    PubMed  Google Scholar 

  4. Christensen D, Laursen H, Klinken L (1983) Prediction of recurrence in meningiomas after surgical treatment. A quantitative approach. Acta Neuropathol 61: 130–134

    Article  PubMed  Google Scholar 

  5. Collins VP, Nordenskjold M, Dumanski JP (1990) The molecular genetics of meningiomas. Brain Pathol 1: 19–24

    PubMed  Google Scholar 

  6. Cruz-Sanchez FF, Miquel R, Rossi ML, Palacin A, Cardesa A (1993) Clinicopathological correlations in meningiomas: DNA and immunohistochemical study. Histol Histopathol 8: 1–8

    PubMed  Google Scholar 

  7. Dinda AK, Kharbanda K, Sarkar C, Roy S, Mathur M, Banerji AK (1993) In-vivo proliferative potential of primary human brain tumors; its correlation with histological classification and morphological features: 11 nonglial tumors. Pathology 25: 10–14

    PubMed  Google Scholar 

  8. Henn W, Cremerius U, Heide G, Lippitz B, Schröder JM, Gilsbach J, Büll U, Zang KD (1995) Monosomy 1p is correlated with enhanced in vivo glucose metabolism in meningiomas. Cancer Genet Cytogenet 79: 144–148

    Article  PubMed  Google Scholar 

  9. Hsu DW, Pardo FS, Efird JT, Linggood RM, Hedley-Whyte ET (1994) Prognostic significance of proliferative indices in meningiomas. J Neuropathol Exp Neurol 53: 247–255

    PubMed  Google Scholar 

  10. Jääskeläinen J (1986) Seemingly complete removal of histologically benign intracranial meningioma: late recurrence in 657 patients. Surg Neurol 26: 461–469

    Article  PubMed  Google Scholar 

  11. Jääskeläinen J, Haltia M, Servo A (1986) Atypical and anaplastic meningiomas: radiology, surgery, radiotherapy, and outcome. Surg Neurol 25: 233–242

    Article  PubMed  Google Scholar 

  12. Jellinger K, Slowik F (1975) Histological subtypes and prognostic problems in meningiomas. J Neurol 208: 279–298

    Article  PubMed  Google Scholar 

  13. Jellinger K, (1988) Histopathologic features predicting recurrence of meningiomas after (sub)total resection. Clin Neuropathol 7: 174 (abstract)

    Google Scholar 

  14. Kharbanda K, Karak AS, Sarkar C, Dinda AK, Mathur M, Roy S (1992) Prediction of biologic aggressiveness in human meningiomas: a cell kinetic study using bromodeoxyuridine in cells of primary expiant culture. J Natl Cancer Inst 84: 194–195

    PubMed  Google Scholar 

  15. Kleihues P, Burger PC, Scheithauer BW (1993) Histological typing of tumours of the central nervous system. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  16. Kolles H, Förderer W, Bock R, Feiden W (1993) Combined Ki-67 and Feulgen stain for morphometric determination of the Ki-67 labelling index. Histochemistry 100: 293–296

    Article  PubMed  Google Scholar 

  17. Kolles H, Ludt H, Vince GH, Feiden W (1994) Application of minimal spanning trees in glioma grading — a CLIPPER program for the calculation of minimal spanning trees. Comput Methods Programs Biomed 42: 201–206

    Article  PubMed  Google Scholar 

  18. Kolles H, v. Wangenheim A, Vince GH, Niedermayer I, Feiden W (1995) Automated grading of astrocytomas based on histomorphometric analysis of Ki-67 and Feulgen stained paraffin sections. Classification results of neuronal networks and discriminant analysis.. Anal Cell Pathol 8: 101–116

    PubMed  Google Scholar 

  19. Kujas M (1993) Meningioma. Curr Opin Neurol 6: 882–887

    PubMed  Google Scholar 

  20. Lang C, Hirschberger W, Schlote W (1993) Proliferation rate in meningiomas: validity of Ki-67 and proliferation-associated nuclear antigen labeling indices. Adv Tech Stand Neurosurg 21: 293–296

    Google Scholar 

  21. Lindblom A, Ruttledge M, Collins VP, Nordenskjöld M, Dumanski JP (1994) Chromosomal deletions in anaplastic meningiomas suggest multiple regions outside chromosome 22 as important in tumour progression. Int J Cancer 56: 354–357

    PubMed  Google Scholar 

  22. Madsen C, Schrøder HD (1993) Sterological estimation of nuclear volume in benign and atypical meningiomas. APMIS 101: 23–26

    PubMed  Google Scholar 

  23. Madsen C, Schrøder HD (1994) Stereological analysis of nuclear volume in recurrent meningiomas. J Neuropathol Exp Neurol 53: 272–275

    PubMed  Google Scholar 

  24. Mahmood A, Caccamo DV, Tomecek FJ, Malik GM (1993) Atypical and malignant meningiomas: a clinicopathological review. Neurosurgery 33: 955–963

    PubMed  Google Scholar 

  25. Maier H, Öfner D, Hittmair A, Kitz K, Budka H (1992) Classic, atypical, and anaplastic meningioma: three histopathological subtypes of clinical relevance. J Neurosurg 77: 616–623

    PubMed  Google Scholar 

  26. Marcelpoil R (1993) Normalization of the minimum spanning tree. Analyt Cell Pathol 5: 177–186

    Google Scholar 

  27. May PL, Broome JC, Lawry J, Buxton RA, Battersby RDE (1989) The prediction of recurrence in meningiomas. A flow cytometric study of paraffin-embedded archival material. J Neurosurg 71: 347–351

    PubMed  Google Scholar 

  28. McLean CA, Jolley D, Cukier E, Giles G, Gonzales MF (1993) Atypical and malignant meningiomas: importance of micronecrosis as a prognostic indicator. Histopathology 23: 349–353

    PubMed  Google Scholar 

  29. Miller RG (1981) Simultaneous statistical interference, 2nd Ed. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  30. Norusis MJ (1988) SPSS/PC + Advanced Statistics V 2.0. Chicago: SPSS Inc., B1-B39

    Google Scholar 

  31. Rey JA, Bello MJ, de Campos JM, Kusak E, Moreno S (1988) Chromosomal involvement secondary to -22 in human meningiomas. Cancer Genet Cytogenet 33: 275–290

    Article  PubMed  Google Scholar 

  32. Roggendorf W, Schuster T, Peiffer J (1987) Proliferative potential of meningiomas determined with the monoclonal antibody Ki-67. Acta Neuropathol (Berl) 73: 361–364

    Article  Google Scholar 

  33. Salmon I, Kiss R, Levivier M, Remmelink M, Pasteeis JL, Brotchi J, Flament-Durant J (1993) Characterization of nuclear DNA content, proliferation index, and nuclear size in a series of 181 meningiomas, including benign primary, recurrent, and malignant tumours. Am J Surg Pathol 17: 239–247

    PubMed  Google Scholar 

  34. Salmon I, Camby I, Gras T, Rombaut K, Pasteels JL, Kiss R (1994) The use of digital cell image analysis of Feulgenstained nuclei to quantitatively describe morphonuclear features in a series of 174 meningiomas. Modern Pathology 7: 570–577

    PubMed  Google Scholar 

  35. Scarpelli M, Montironi R, Sisti S, Mariuzzi M, Brancorsini D, Rychlicki F, Ansuini G (1989) Quantitative evaluation of recurrent meningiomas. Path Res Pract 185: 746–751

    PubMed  Google Scholar 

  36. Scheithauer BW (1990) Tumors of the meninges: proposed modifications of the World Health Organization classification. Acta Neuropathol 80: 343–354

    Article  PubMed  Google Scholar 

  37. Schröder R, Bien K, Kott R, Meyers I, Vössing R (1991) The relationship between Ki-67 labeling and mitotic index in gliomas and meningiomas: demonstration of the variability of the intermitotic cycle time. Acta Neuropathol 82: 389–394

    Article  PubMed  Google Scholar 

  38. Seabright M (1971) A rapid technique for banding human chromosomes. Lancet 11: 971–972

    Article  Google Scholar 

  39. Shibuya M, Hoshino T, Ito S, Wacker MR, Prados MD, Davis RL, Wilson CB (1992) Meningiomas: clinical implications of a high proliferative potential determined by bromodeoxyuridine labeling. Neurosurgery 30: 494–498

    PubMed  Google Scholar 

  40. Steudel WI, Feld R, Henn W, Zang KD (1994) Correlation between cytogenetic and clinical findings in 215 human meningiomas. Zentralbl Neurochir [Suppl]: 42 (abstract)

    Google Scholar 

  41. Strachan R, Clarke C, Nurbhai M, Marks S (1989) Will chromosome karyotyping of meningiomas aid prediction of tumor recurrence? Br J Neurosurg 3: 583–590

    PubMed  Google Scholar 

  42. Vagner-Capodano AM, Grisoli F, Gambarelli D, Sedan R, Pellet W, De Victor B (1993) Correlation between cytogenetic and histopathological findings in 75 human meningiomas. Neurosurgery 32: 892–900

    PubMed  Google Scholar 

  43. Zang KD, Singer H (1967) Chromosomal constitution of meningiomas. Nature 216: 84–85

    PubMed  Google Scholar 

  44. Zang KD (1982) Cytological and cytogenetical studies on human meningioma. Cancer Genet Cytogenet 6: 249–274

    Article  PubMed  Google Scholar 

  45. Zankl H, Zang KD (1972) Cytological and cytogenetical studies on brain tumors. Identification of the missing G chromosome in human meningiomas as no. 22 by fluorescence technique. Human Genetics 14: 167–169

    Article  PubMed  Google Scholar 

  46. Zankl H, Zang KD (1980) Correlation between clinical and cytogenetical data in 180 human meningiomas. Cancer Genet Cytogenet 1: 351–356

    Article  Google Scholar 

  47. Zimmer C, Gottschalk J, Cervos-Navarro J, Martin H, Beil M, Jautzke G (1992) Proliferating cell nuclear antigen (PCNA) in atypical and malignant meningiomas. Path Res Pract 188: 951–958

    PubMed  Google Scholar 

  48. Zülch KJ, Mennel HD (1975) Malignant meningiomas. Adv Neurosurg 2: 3–11

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kolles, H., Niedermayer, I., Schmitt, C. et al. Triple approach for diagnosis and grading of meningiomas: Histology, morphometry of Ki-67/feulgen stainings, and cytogenetics. Acta neurochir 137, 174–181 (1995). https://doi.org/10.1007/BF02187190

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02187190

Keywords

Navigation